The GI training program of the Massachusetts General Hospital (MGH) remains dedicated to the preparation of investigators committed to a career in GI biomedical research. This program continues to build on its extensive past experience in training productive and committed digestive diseases investigators (94% of trainees in past 10 years remain in academic GI). Fundamental features of the post-doctoral training format, the major component of this program, include direct research participation in conjunction with a comprehensive program of didactic instruction and enrichment activities to provide a deep foundation in biomedical science and modern research techniques. In addition, continuation of a two-year pre-doctoral laboratory research program is proposed to attract promising underrepresented minorities, to careers in GI research at a critical juncture in their careers. Research Areas and Disciplines. The strength of the research base of this program encompasses a spectrum of research interests. The majority of trainees will undertake training in laboratory research in which emphasis is placed on the application of tools of molecular biology to GI research. Training is offered in several disciplines central to the study of digestive diseases: Epithelial Biology, Developmental Biology, Immunology, Metabolism, Host-Pathogen Interactions, Genetics, Cancer Biology, Stem Cell Biology, Systems Biology, and Tissue Engineering. For fellows undertaking training in clinical investigation, a rigorous preparation in relevant quantitative sciences, including Biostatistics and Epidemiology, is provided. In all disciplines, updated formal work in the Responsible Conduct of Research is offered. Level of Training, Background and Numbers of Trainees. This renewal proposes both post-doctoral and pre-doctoral training. Post-doctoral training is offered to individuals holding M.D., M.D.-Ph.D. or relevant Ph.D. degrees. Seven post-doctoral positions are requested: four post-doctoral fellows will begin training each year, and remain in research training for a minimum of two years supported by this award. In addition, two positions are requested to continue the pre-doctoral training fellowship for URMs completing an undergraduate degree or enrolled in graduate or medical school, each student entering for a 1-2 year period. Training Facilities. Research training will take place in the existing laboratories of the research mentors;a group of 57 established investigators with extensive ongoing interactions. Laboratories are present at the MGH, a large general hospital with more than 1,300,000 sq. ft. of space dedicated to research. In addition, training opportunities will be available in laboratories elsewhere at Harvard, M.I.T., and the Broad Institute. Didactic educational programs will include those offered through the Harvard Medical School, other affiliates of the Harvard Medical School, the Harvard School of Public Health, Harvard University and M.I.T.

Public Health Relevance

The training of the next generation of knowledge creators in digestive diseases will require concerted efforts to harness the explosion of information that has been created by annotation of the human genome and other technologies. Now more than ever, a planned approach to the research career development of physician scientists becomes critical to maximize likelihood of success, one that must incorporate solid scientific environment, mentorship, didactic curriculum, monitoring, and interaction. We have retained preceptors from a stellar group of fundamental, translational and clinical scientists who have adapted and incorporated these recent advances to preserve a training environment that has had an exceptional track record of producing leaders in academic gastroenterology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
3T32DK007191-40S1
Application #
8867747
Study Section
Digestive Diseases and Nutrition C Subcommittee (DDK)
Program Officer
Densmore, Christine L
Project Start
1976-07-01
Project End
2016-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
40
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Chhatwal, J; Chen, Q; Ayer, T et al. (2018) Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA. Aliment Pharmacol Ther 47:1023-1031
Graham, Daniel B; Jasso, Guadalupe J; Mok, Amanda et al. (2018) Nitric Oxide Engages an Anti-inflammatory Feedback Loop Mediated by Peroxiredoxin 5 in Phagocytes. Cell Rep 24:838-850
Bhan, Irun; Mosesso, Kelly; Goyal, Lipika et al. (2018) Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies From Patients With Liver Disease. Gastroenterology 155:2016-2018.e11
Chhatwal, Jagpreet; Samur, Sumeyye; Bethea, Emily D et al. (2018) Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study. Hepatology 67:2085-2095
Bethea, Emily D; Chen, Qiushi; Hur, Chin et al. (2018) Should we treat acute hepatitis C? A decision and cost-effectiveness analysis. Hepatology 67:837-846
Simon, Tracey G; King, Lindsay Y; Chong, Dawn Q et al. (2018) Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology 67:1797-1806
Takahashi, Melissa K; Tan, Xiao; Dy, Aaron J et al. (2018) A low-cost paper-based synthetic biology platform for analyzing gut microbiota and host biomarkers. Nat Commun 9:3347
Pereira, Ethel R; Kedrin, Dmitriy; Seano, Giorgio et al. (2018) Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 359:1403-1407
Kubiliun, Maddie; Patel, Suraj J; Hur, Chin et al. (2018) Early liver transplantation for alcoholic hepatitis: Ready for primetime? J Hepatol 68:380-382
Chen, Jennifer Y; Newcomb, Benjamin; Zhou, Chan et al. (2017) Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells. Sci Rep 7:44867

Showing the most recent 10 out of 149 publications